Northeast Pharmaceutical Group Co., Ltd.
SZSE:000597.SZ
5.01 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 8,243.175 | 8,808.943 | 8,145.117 | 7,384.354 | 8,220.103 | 7,466.555 | 5,676.352 | 4,814.402 | 3,834.432 | 4,333.322 | 3,870.591 | 3,864.913 | 3,882.78 | 4,828.746 | 5,093.588 | 4,609.773 | 3,706.074 | 1,918.238 | 1,833.077 | 1,619.687 | 1,606.877 | 1,396.982 | 1,441.98 | 1,197.568 | 1,011.546 | 760.618 | 757.452 | 1,166.075 | 1,049.725 | 934.591 | 1,001.844 |
Cost of Revenue
| 5,124.892 | 5,377.394 | 4,928.938 | 4,492.672 | 4,637.994 | 4,377.191 | 3,431.799 | 3,295.117 | 2,817.137 | 2,967.058 | 2,675.82 | 2,908.446 | 3,090.166 | 3,697.841 | 3,535.872 | 3,031.524 | 2,983.679 | 1,497.627 | 1,410.605 | 1,243.732 | 1,227.195 | 1,111.511 | 1,131.753 | 897.565 | 734.714 | 560.429 | 608.213 | 1,018.179 | 891.206 | 716.583 | 727.059 |
Gross Profit
| 3,118.283 | 3,431.549 | 3,216.18 | 2,891.682 | 3,582.109 | 3,089.364 | 2,244.553 | 1,519.284 | 1,017.295 | 1,366.264 | 1,194.771 | 956.467 | 792.613 | 1,130.905 | 1,557.717 | 1,578.25 | 722.395 | 420.611 | 422.472 | 375.955 | 379.683 | 285.47 | 310.227 | 300.003 | 276.832 | 200.189 | 149.24 | 147.895 | 158.519 | 218.008 | 274.785 |
Gross Profit Ratio
| 0.378 | 0.39 | 0.395 | 0.392 | 0.436 | 0.414 | 0.395 | 0.316 | 0.265 | 0.315 | 0.309 | 0.247 | 0.204 | 0.234 | 0.306 | 0.342 | 0.195 | 0.219 | 0.23 | 0.232 | 0.236 | 0.204 | 0.215 | 0.251 | 0.274 | 0.263 | 0.197 | 0.127 | 0.151 | 0.233 | 0.274 |
Reseach & Development Expenses
| 97.042 | 160.389 | 83.459 | 74.181 | 63.938 | 144.67 | 57.657 | 30.9 | 26.259 | 18.791 | 15.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 769.199 | 267.928 | 307.803 | 304.663 | 190.133 | 144.144 | 273.408 | 141.735 | 202.078 | 182.989 | 235.501 | 262.742 | 347.812 | 222.768 | 409.041 | 348.096 | 192.954 | 172.517 | 193.913 | 173.492 | 170.615 | 104.745 | 116.434 | 135.648 | 123.617 | 53.441 | 67.83 | 78.499 | 55.858 | 74.975 | 93.766 |
Selling & Marketing Expenses
| 1,809.717 | 2,050.901 | 2,016.307 | 1,744.877 | 2,295.206 | 1,918.288 | 1,121.589 | 737.165 | 632.683 | 636.651 | 590.934 | 522.487 | 420.228 | 423.356 | 458.127 | 341.905 | 245.346 | 164.397 | 137.378 | 123.145 | 140.712 | 102.625 | 90.793 | 74.511 | 52.803 | 30.843 | 23.063 | 36.131 | 36.795 | 29.946 | 29.646 |
SG&A
| 2,573.293 | 2,318.829 | 2,324.11 | 2,049.541 | 2,485.34 | 2,062.432 | 1,394.997 | 878.9 | 834.761 | 819.64 | 826.434 | 785.229 | 768.04 | 646.124 | 867.168 | 690.001 | 438.3 | 336.914 | 331.291 | 296.637 | 311.328 | 207.37 | 207.227 | 210.159 | 176.42 | 84.284 | 90.893 | 114.63 | 92.654 | 104.921 | 123.412 |
Other Expenses
| -50.278 | 498.236 | 452.333 | 442.046 | 584.89 | 137.775 | -12.359 | 43.35 | 26.468 | 112.621 | 44.592 | 377.33 | 89.007 | 98.748 | 71.996 | 5.446 | 31.515 | 8.409 | -11.397 | -3.957 | 0.904 | -0.713 | -4.477 | 1.938 | 23.099 | 14.999 | -72.366 | -0.142 | 12.407 | 9.994 | 4.846 |
Operating Expenses
| 2,620.058 | 2,977.454 | 2,859.902 | 2,565.768 | 3,134.167 | 2,617.664 | 1,878.814 | 1,323.664 | 1,214.148 | 1,181.97 | 1,227.671 | 1,116.966 | 1,103.198 | 951.243 | 905.004 | 723.706 | 452.824 | 344.649 | 341.897 | 301.215 | 314.952 | 212.391 | 212.009 | 214.319 | 181.106 | 85.993 | 93.095 | 115.844 | 93.804 | 108.263 | 181.21 |
Operating Income
| 498.226 | 367.382 | 348.344 | 279.04 | 489.337 | 75.961 | 114.532 | 1.597 | -403.166 | 7.149 | -202.884 | -332.399 | -469.622 | 37.869 | 532.4 | 494.953 | 101.978 | 51.687 | 48.85 | 30.609 | 8.365 | 14.421 | 25.553 | 37.738 | 48.904 | 77.864 | 13.006 | 25.547 | 49.409 | 72.36 | 47.489 |
Operating Income Ratio
| 0.06 | 0.042 | 0.043 | 0.038 | 0.06 | 0.01 | 0.02 | 0 | -0.105 | 0.002 | -0.052 | -0.086 | -0.121 | 0.008 | 0.105 | 0.107 | 0.028 | 0.027 | 0.027 | 0.019 | 0.005 | 0.01 | 0.018 | 0.032 | 0.048 | 0.102 | 0.017 | 0.022 | 0.047 | 0.077 | 0.047 |
Total Other Income Expenses Net
| -10.054 | -170.915 | -67.187 | -61.312 | 14.289 | 137.775 | -12.359 | 35.831 | -3.726 | 98.598 | 43.92 | 374.851 | 86.593 | -88.426 | 51.969 | 4.722 | -137.647 | -1.248 | -39.066 | -40.452 | -4.24 | -8.535 | -8.233 | -10.522 | 1.489 | -29.956 | -82.247 | -1.988 | 9.74 | 1.762 | 5.932 |
Income Before Tax
| 488.172 | 525.441 | 120.163 | 91.838 | 224.245 | 213.736 | 102.173 | 37.428 | -406.892 | 105.748 | -158.964 | 42.452 | -381.236 | 77.142 | 584.378 | 499.675 | 131.923 | 48.608 | 39.481 | 30.47 | 4.126 | 5.886 | 21.553 | 36.593 | 50.393 | 80.594 | -69.242 | 23.559 | 59.149 | 74.122 | 53.421 |
Income Before Tax Ratio
| 0.059 | 0.06 | 0.015 | 0.012 | 0.027 | 0.029 | 0.018 | 0.008 | -0.106 | 0.024 | -0.041 | 0.011 | -0.098 | 0.016 | 0.115 | 0.108 | 0.036 | 0.025 | 0.022 | 0.019 | 0.003 | 0.004 | 0.015 | 0.031 | 0.05 | 0.106 | -0.091 | 0.02 | 0.056 | 0.079 | 0.053 |
Income Tax Expense
| 112.194 | 168.393 | 24.722 | 81.011 | 53.805 | 12.367 | 10.115 | 11.083 | -14.742 | 21.927 | 6.236 | 37.025 | 0.236 | 23.303 | 108.295 | 141.738 | 84.93 | 28.982 | 26.13 | 22.342 | 8.791 | -4.207 | 11.483 | 7.75 | 7.013 | 12.426 | -53.02 | 3.614 | 12.045 | 10.9 | 9.407 |
Net Income
| 358.458 | 350.253 | 99.027 | 12.257 | 173.978 | 195.2 | 118.995 | 23.788 | -384.358 | 87.075 | -166.963 | 8.104 | -389.961 | 50.011 | 476.079 | 357.906 | 47.521 | 19.626 | 13.351 | 8.129 | 8.685 | 10.19 | 10.113 | 28.851 | 43.379 | 68.166 | -69.242 | 19.945 | 47.105 | 63.222 | 44.014 |
Net Income Ratio
| 0.043 | 0.04 | 0.012 | 0.002 | 0.021 | 0.026 | 0.021 | 0.005 | -0.1 | 0.02 | -0.043 | 0.002 | -0.1 | 0.01 | 0.093 | 0.078 | 0.013 | 0.01 | 0.007 | 0.005 | 0.005 | 0.007 | 0.007 | 0.024 | 0.043 | 0.09 | -0.091 | 0.017 | 0.045 | 0.068 | 0.044 |
EPS
| 0.25 | 0.26 | 0.074 | 0.01 | 0.14 | 0.16 | 0.11 | 0.023 | -0.36 | 0.099 | -0.23 | 0.009 | -0.53 | 0.072 | 0.64 | 0.52 | 0.07 | 0.037 | 0.014 | 0.007 | 0.01 | 0.011 | 0.004 | 0.021 | 0.047 | 0.039 | -0.1 | 0.022 | 0.067 | 0.094 | 0.065 |
EPS Diluted
| 0.25 | 0.26 | 0.074 | 0.01 | 0.14 | 0.16 | 0.11 | 0.023 | -0.36 | 0.099 | -0.23 | 0.009 | -0.53 | 0.072 | 0.64 | 0.52 | 0.07 | 0.037 | 0.014 | 0.007 | 0.01 | 0.011 | 0.004 | 0.021 | 0.047 | 0.039 | -0.1 | 0.022 | 0.067 | 0.094 | 0.065 |
EBITDA
| 1,196.466 | 928.488 | 837.04 | 693.463 | 690.209 | 497.743 | 594.583 | 500.923 | -40.26 | 449.959 | 151.393 | 351.45 | -49.898 | 389.624 | 809.725 | 716.071 | 303.76 | 170.846 | 161.983 | 136.832 | 135.317 | 134.276 | 140.228 | 129.475 | 131.907 | 128.162 | 56.145 | 32.051 | 64.715 | 109.745 | 93.575 |
EBITDA Ratio
| 0.145 | 0.105 | 0.11 | 0.103 | 0.101 | 0.128 | 0.122 | 0.121 | 0.019 | 0.112 | 0.042 | 0.099 | -0.001 | 0.096 | 0.168 | 0.205 | 0.104 | 0.088 | 0.089 | 0.086 | 0.084 | 0.096 | 0.1 | 0.116 | 0.13 | 0.206 | 0.074 | 0.027 | 0.062 | 0.117 | 0.093 |